AAPL

TSLA

AMZN

META

AMD

NVDA

PEP

COST

ADBE

GOOG

AMGN

HON

INTC

INTU

NFLX

ADP

SBUX

MRNA

Markets

GXC

We Did The Math GXC Can Go To $124

April 03, 2026 — 09:17 am EDT

Written by

BNK Invest for

BNK Invest->

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P China ETF (Symbol: GXC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $124.19 per unit.

With GXC trading at a recent price near $92.21 per unit, that means that analysts see 34.69% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of GXC's underlying holdings with notable upside to their analyst target prices are Legend Biotech Corp (Symbol: LEGN), Structure Therapeutics Inc (Symbol: GPCR), and VNET Group Inc (Symbol: VNET). Although LEGN has traded at a recent price of $19.14/share, the average analyst target is 216.78% higher at $60.63/share. Similarly, GPCR has 103.81% upside from the recent share price of $53.48 if the average analyst target price of $109.00/share is reached, and analysts on average are expecting VNET to reach a target price of $16.34/share, which is 99.55% above the recent price of $8.19. Below is a twelve month price history chart comparing the stock performance of LEGN, GPCR, and VNET:

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target SPDR S&P China ETF GXC $92.21 $124.19 34.69% Legend Biotech Corp LEGN $19.14 $60.63 216.78% Structure Therapeutics Inc GPCR $53.48 $109.00 103.81% VNET Group Inc VNET $8.19 $16.34 99.55%Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

10 ETFs With Most Upside To Analyst Targets »

Also see:

YTD Return

SMCI Videos

High Yield Stocks

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.